Preoperative radiotherapy for resectable rectal cancer -: A meta-analysis

被引:563
|
作者
Cammà, C
Giunta, M
Fiorica, F
Pagliaro, L
Craxì, A
Cottone, M
机构
[1] Univ Palermo, Ist Clin Med, Cattedra Gastroenterol, I-90127 Palermo, Italy
[2] CNR, Ist Metodol Diagnost Avanzate, Palermo, Italy
[3] Univ Palermo, Ist Med Gen & Pneumol, Palermo, Italy
来源
关键词
D O I
10.1001/jama.284.8.1008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The benefit of adjuvant radiotherapy for resectable rectal cancer has been extensively studied, but data on survival are still equivocal despite a reduction in the rate of local recurrence. Objective To assess the effectiveness of preoperative radiotherapy followed by surgery in the reduction of overall and cancer-related mortality and in the prevention of local recurrence and distant metastases. Data Sources Computerized bibliographic searches of MEDLINE and CANCERLIT (1970 to December 1999), including non-English sources, were supplemented with hand searches of reference lists. The medical subject headings used were rectal cancer, radiotherapy, surgery, RCT, randomized, and clinical trial, Study Selection Studies were included if they were randomized controlled trials (RCTs) comparing preoperative radiotherapy plus surgery with surgery alone and if they included patients with resectable histologically proven rectal adenocarcinoma, without metastatic disease. Fourteen RCTs were analyzed. Data Extraction Data on population, intervention, and outcomes were extracted from each RCT according to the intention-to-treat method by 3 independent observers and combined using the DerSimonian and Laird method. Data Synthesis Radiotherapy plus surgery compared with surgery alone significantly reduced the 5-year overall mortality rate (odds ratio [OR] 0.84; 95% confidence interval [CI], 0.72-0.98; P=.03), cancer-related mortality rate (OR, 0.71; 95% CI, 0.61-0.82; P<.001), and local recurrence rate (OR, 0.49; 95% CI, 0.38-0.62; P<.001). No reduction was observed in the occurrence of distant metastases (OR, 0.93; 95% ci, 0.73-1.18; P=.54). Conclusions In patients with resectable rectal cancer, preoperative radiotherapy significantly improved overall and cancer-specific survival compared with surgery alone. The magnitude of the benefit is relatively small and criteria are needed to identify patients most likely to benefit from adjuvant radiotherapy.
引用
收藏
页码:1008 / 1015
页数:8
相关论文
共 50 条
  • [1] Preoperative radiotherapy in resectable rectal cancer: A meta-analysis of randomized controlled trials.
    Giunta, M
    Camma, C
    Fiorica, F
    Craxi', A
    Pagliaro, L
    Cottone, M
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A412 - A412
  • [2] ANORECTAL FUNCTION AFTER PREOPERATIVE RADIOTHERAPY FOR RECTAL CANCER: A META-ANALYSIS
    Flores, H.
    Velasquez, M.
    Estanislao, N.
    Ang, E.
    Tripon, E.
    Daez, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 109 - 109
  • [3] Improved survival with preoperative radiotherapy in resectable rectal cancer
    Pahlman, L
    Glimelius, B
    Cedermark, B
    Lundell, G
    Rubio, C
    Rutqvist, LE
    Wilking, N
    Ost, A
    Brismar, B
    Ewerth, S
    Forsgren, L
    Johansson, C
    Magnusson, I
    Sundelin, P
    Svensson, C
    Tornberg, B
    Theve, T
    Fenyo, G
    Svensson, SO
    Goldman, S
    Molin, K
    Bark, S
    Sundblad, M
    Dalen, J
    Lindholmer, C
    Robertsson, B
    Ohman, U
    Nilsson, SE
    Dahlberg, M
    Graf, W
    JanssonFrykholm, G
    Lindmark, G
    Westman, M
    Liljeholm, H
    Bendtsen, O
    Ljungquist, U
    Nihlberg, A
    Heuman, R
    Lorentz, T
    BisgaardPedersen, A
    Bergstrom, S
    Krog, M
    Tuvesson, T
    Edman, P
    Lindstrom, C
    Sandhammar, B
    Tyden, G
    Bergman, L
    Enander, LK
    Underskog, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14): : 980 - 987
  • [4] Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis
    Wang Qiaoli
    Huang Yongping
    Xiong Wei
    Xu Guoqiang
    Ju Yunhe
    Liu Qiuyan
    Li Cheng
    Guo Mengling
    Li Jiayi
    Xiong Wei
    Yang Yi
    [J]. International Journal of Colorectal Disease, 2019, 34 : 2171 - 2183
  • [5] Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis
    Zhong, Wei
    Xue, Xiaojun
    Dai, Lianzhi
    Li, Ranran
    Nie, Kai
    Zhou, Song
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (04) : 2604 - 2614
  • [6] Preoperative chemoradiation vs radiation alone for stage II and III resectable rectal cancer: a meta-analysis
    Latkauskas, T.
    Paskauskas, S.
    Dambrauskas, Z.
    Gudaityte, J.
    Saladzinskas, S.
    Tamelis, A.
    Pavalkis, D.
    [J]. COLORECTAL DISEASE, 2010, 12 (11) : 1075 - 1083
  • [7] Preoperative short-course radiotherapy (5 x 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis
    Wang Qiaoli
    Huang Yongping
    Xiong Wei
    Xu Guoqiang
    Ju Yunhe
    Liu Qiuyan
    Li Cheng
    Guo Mengling
    Li Jiayi
    Yang Yi
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (12) : 2171 - 2183
  • [8] Resectable Rectal Cancer: Which Patient Does Not Need Preoperative Radiotherapy?
    Kulu, Yakup
    Ulrich, Alexis
    Buechler, Markus W.
    [J]. DIGESTIVE DISEASES, 2012, 30 : 118 - 125
  • [9] Does preoperative radiotherapy improve outcome in patients with resectable rectal cancer?
    Veness, MJ
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (10) : 563 - 564
  • [10] Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
    Kapiteijn, E
    Marijnen, CAM
    Nagtegaal, ID
    Putter, H
    Steup, WH
    Wiggers, T
    Rutten, HJT
    Pahlman, L
    Glimelius, B
    van Krieken, JHJM
    Leer, JWH
    van de Velde, CJH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (09): : 638 - 646